Talk:Post-LASIK ectasia

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.
	This article is supported by the Ophthalmology task force.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Post-LASIK ectasia.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Link to FDA[edit]

Unable to find a link from the FDA?

"On July 19, 2016, FDA has approved Avedro's KXL system and two photoenhancers for the treatment of corneal ectasia following refractive surgery.^[1]^[2]" Doc James (talk · contribs · email) 18:19, 4 August 2016 (UTC)[reply]

See this document on FDA. it mentions "recent major changes" in July 2016 for "indications and usage", "PHOTREXA VISCOUS and PHOTREXA are photoenhancers indicated for use with the KXL System in corneal collagen cross-linking for the treatment of progressive keratoconus (1.1) and corneal ectasia following refractive surgery (1.2)". k18s (talk) 02:37, 6 August 2016 (UTC)[reply]

References

^ "FDA approves Avedro's cross-linking system for corneal ectasia following refractive surgery". July 19, 2016.
^ "Avedro Receives Additional Indication for Photrexa® Viscous, Photrexa® and the KXL® System for the Treatment of Corneal Ectasia following Refractive Surgery". avedro.com. Jul 19, 2016.

[1] "FDA approves Avedro's cross-linking system for corneal ectasia following refractive surgery". July 19, 2016.

[2] "Avedro Receives Additional Indication for Photrexa® Viscous, Photrexa® and the KXL® System for the Treatment of Corneal Ectasia following Refractive Surgery". avedro.com. Jul 19, 2016.

[1]

[2]